Empowered Funds’s Medpace MEDP Stock Holding History

Empowered Funds’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,007	Closed	-$1.7M	–	631
2022 Q4	$1.7M	Buy	+8,007	New	+$1.6M	0.11%	195

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Empowered Funds's MEDP Position: Q1 2026 in Review

Empowered Funds increased its Medpace (MEDP) stake by 31% in Q1 2026, buying an estimated $3.13M and bringing the position to 25,730 shares worth $12.4M. The position accounts for 0.08% of the portfolio, ranked #293.

Empowered Funds first reported a position in MEDP in Q3 2022 and has held it in 14 quarters since. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Empowered Funds held 25,730 shares of Medpace worth $12.4M as of Q1 2026.
Empowered Funds bought 6,113 Medpace shares in Q1 2026, an estimated $3.13M.
Medpace made up 0.08% of Empowered Funds's portfolio in Q1 2026, its #293 holding.
Empowered Funds first reported a position in Medpace in Q3 2022 and has held it in 14 quarters since.
729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.